Share This Article:

Drivers and Patterns of Supply Chain Collaboration in the Pharmaceutical Industry: A Case Study on SMEs in China

Abstract Full-Text HTML XML Download Download as PDF (Size:372KB) PP. 23-29
DOI: 10.4236/jss.2015.37004    4,025 Downloads   4,796 Views   Citations

ABSTRACT

The objectives of this paper are to identify the supply chain collaboration models/patterns and its correspondent advantages on pharmaceutical supply chain. This paper aims to investigate how collaborative activities can impact on the development of supply chain and industry. A case study methodology was adopted in this research, which involved pharmaceutical SMEs. The results indicate that collaborations are common in all phases of pharmaceutical supply chain; the different strength of barging power among collaborative partners will impact the advantages achieved at strategic, operational and political levels.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Huang, L. , Lin, Y. , Ieromonachou, P. , Zhou, L. and Luo, J. (2015) Drivers and Patterns of Supply Chain Collaboration in the Pharmaceutical Industry: A Case Study on SMEs in China. Open Journal of Social Sciences, 3, 23-29. doi: 10.4236/jss.2015.37004.

References

[1] Cao, M. and Zhang, Q. (2011) Supply Chain Collaboration: Impact on Collaborative Advantage and Firm Performance. Journal of Operation Management, 29, 163-180. http://dx.doi.org/10.1016/j.jom.2010.12.008
[2] Liao, S.-H. and Kuo, F.-K. (2014) The Study of Relationships between the Collaboration for Supply Chain, Supply Chain Capabilities and Firm Performance: A Case of the Taiwan’s TFT-LCD Industry. International Journal of Production Economics, 156, 295-304. http://dx.doi.org/10.1016/j.ijpe.2014.06.020
[3] Kafouros, M., Wang, C., Piperopoulos, P. and Zhang, M. (2015) Academic Collaborations and Firm Innovation Performance in China: The Role of Region-Specific Institutions. Research Policy, 44, 803-817. http://dx.doi.org/10.1016/j.respol.2014.11.002
[4] Montoya-Torres, J.R. and Ortiz-Vargas, D.A. (2014) Collaboration and Information Sharing in Dyadic Supply Chain: A Literature Review over the Period 2000-2012. Estudios Gerenciales, 30, 343-354. http://dx.doi.org/10.1016/j.estger.2014.05.006
[5] Ramanathan, U. (2014) Performance of Supply Chain Collaboration—A Simulation Study. Expert Systems with Applications, 41, 210-220. http://dx.doi.org/10.1016/j.eswa.2013.07.022
[6] Shah, N. (2004) Pharmaceutical Supply Chains: Key Issues and Strategies for Optimization. Computers and Chemical Engineering, 28, 929-941. http://dx.doi.org/10.1016/j.compchemeng.2003.09.022
[7] Forster, S.P., Stegmaier, J., Spyher, R. and Seeger, S. (2014) Virtual Pharmaceutical Companies: Collaborating Flexibly in Pharmaceutical Development. Drug Discovery Today, 19, 348-355. http://dx.doi.org/10.1016/j.drudis.2013.11.015
[8] Laínez, J.M., Schaefer, E. and Reklaitis, G.V. (2012) Challenges and Opportunities in Enterprise-Wide Optimization in the Pharmaceutical Industry. Computers and Chemical Engineering, 47, 19-28. http://dx.doi.org/10.1016/j.compchemeng.2012.07.002
[9] Rees, H. (2011) Supply Chain Management in the Drug Industry. John Wiley & Sons, Inc.
[10] Koh, R., Schuster, E.W., Chackrabarti, I. and Bellman, A. (2003) White Paper: Securing the Pharmaceutical Supply Chain. Auto-ID Centre, Mit-AutoID-WH-21.
[11] Yu, X., Li, C., Shi, Y. and Yu, M. (2010) Pharmaceutical Supply Chain in China: Current Issues and Implications for Health System Reform. Health Policy, 97, 8-15. http://dx.doi.org/10.1016/j.healthpol.2010.02.010
[12] The State Council of the People’s Republic of China (2012) The Twelfth 5-Year Healthcare Development Plan of China. http://www.gov.cn
[13] Yu, Y., Ma, Z., Hu, H. and Wang, Y. (2013) Local Government Policies and Pharmaceutical clusters in China. Journal of Science and Technology Policy Management, 5, 41-58. http://dx.doi.org/10.1108/JSTPM-02-2013-0004
[14] Huang, S. (2012) How Can Innovation Create the Future in a Catching-Up Economy? Focusing on China’s Pharmaceutical Industry. Journal of Knowledge-Based Innovation in China, 4, 118-131. http://dx.doi.org/10.1108/17561411211235721
[15] PricewaterhouseCoopers (2007) Pharma 2020: The Vision Which Path Will You Take? Pharmaceutical and Life Sciences. http://www.pwc.com/gx/en/pharma-life-sciences/pharma-2020/pharma-2020-vision-path.jhtml
[16] Meng, Q., Cheng, G., Silver, L., Sun, X., Rehnberg, C. and Tomason, G. (2005) The Impact of China’s Retail Drug Price Control Policy on Hospital Expenditures: A Case Study in Two Shandong Hospitals. Health Policy and Planning, 20, 185-196.
[17] Zhang, M., Pawar, K.S., Shah, J. and Mehta, P. (2012) Evaluating Outsourcing Partners’ Capability: A Case Study from the Pharmaceutical Supply Chain. Journal of Manufacturing Technology Management, 24, 1080-1101. http://dx.doi.org/10.1108/JMTM-02-2012-0023
[18] Abudul-Halim, H., Ahmad, N.H. and Ramayah, T. (2015) Unveiling the Motivation to Outsource among SMEs. Business Strategy Series, 13, 181-186. http://dx.doi.org/10.1108/17515631211246258
[19] Bales, R.R., Maull, R.S. and Radnor, Z. (2004) The Development of Supply Chain Management within the Aerospace Manufacture. Supply Chain Management: An International Journal, 9, 250-255. http://dx.doi.org/10.1108/13598540410544944
[20] Pedroso, M.C. and Nakano, D. (2009) Knowledge and Information Flows in Supply Chains: A Study on Pharmaceutical Companies. International Journal of Production Economics, 122, 376-384. http://dx.doi.org/10.1016/j.ijpe.2009.06.012
[21] Narayana, S.A., Pati, R.K. and Vrat, P. (2014) Managerial Research on the Pharmaceutical Supply Chain—A Critical Review and Some Insights for Future Directions. Journal of Purchasing and Supply Management, 20, 18-40. http://dx.doi.org/10.1016/j.pursup.2013.09.001
[22] Scherre-Rathje, M., Deflorin, P. and Anand, G. (2014) Manufacturing Flexibility through Outsourcing: Effects of Contingencies. International Journal of Operations and Production Management, 34, 1210-1242. http://dx.doi.org/10.1108/IJOPM-01-2012-0033
[23] Boulaksil, Y. and Fransoo, J.C. (2010) Implications of Outsourcing on Operations Planning: findings from the pharmaceutical industry. International Journal of Operations and Production Management, 30, 1059-1079. http://dx.doi.org/10.1108/01443571011082526
[24] Sousa, R.T., Shah, N. and Papageorgiou, L.G. (2005) Global Supply Chain Network Optimisation for Pharmaceuticals. Computer Aided Chemical Engineering, 20, 1189-1194. doi:10.1016/S1570-7946(05)80040-9
[25] Scarlett, J.A. (1996) Outsourcing Process-Development and Manufacturing of rDNA-Derived Products. Trends in Biotechnology, 14, 239-244. http://dx.doi.org/10.1016/0167-7799(96)10032-9
[26] Agarwal (2012) Chemistry and Integrated Services in Emerging Countries: How Is the Pharmaceutical Value Chain Changing with Companies Demanding Chemistry and a Provider in Emerging Countries and What Are Suppliers Doing to Upgrade the Offerings and Mitigate the Business Risk? Drug Discovery Today, 17, 1251-1253. http://dx.doi.org/10.1016/j.drudis.2012.09.005
[27] Zhou, E.Y. (2007) China Today—Pharmaceutical Distribution in China: The Country Strive to Modernize Its Distribution Logistics as Thousands of Small Companies Compete for Profits. Biopharm International, 20, 8-24.
[28] Azzi, A., Persona, A., Sgarbossa, F. and Bonin, M. (2013) Drug Inventory Management and Distribution: Outsourcing Logistics to Third-Party Providers. Strategic Outsourcing: An International Journal, 6, 48-64. http://dx.doi.org/10.1108/17538291311316063
[29] Lim, K. (2004) The Relationship between Research and Innovation in the Semiconductor and Pharmaceutical Industries (1981-1997). Research Policy, 33, 287-321. http://dx.doi.org/10.1016/j.respol.2003.08.001
[30] Takayama, M., Watanabe, C. and Griffy-Brown, C. (2002) Alliance Strategy as a Competitive Strategy for Successively Creative New Product Development: The Proof of the Co-Evolution of Creativity and Efficiency in the Japanese Pharmaceutical Industry. Technovation, 22, 607-614. http://dx.doi.org/10.1016/S0166-4972(01)00062-1
[31] PricewaterhouseCoopers (2012) Ensuring Pharmaceutical Supply Chain Effectiveness. Pharmaceutical and Life Sciences. http://www.pwc.com/gx/en/pharma-life-sciences/supply-chain-effectiveness/index.jhtml
[32] Spithoven, A. and Teirlinck, P. (2015) Internal Capabilities, Network Resources and Appropriation Mechanisms as Determinants of R & D Outsourcing. Research Policy, 44, 711-725. http://dx.doi.org/10.1016/j.respol.2014.10.013
[33] Baloh, P., Jha, S. and Awazu, Y. (2008) Building Strategic Partnerships for Managing Innovation Outsourcing. Strategic Outsourcing: An International Journal, 1, 100-121. http://dx.doi.org/10.1108/17538290810897138
[34] Sahay, B.S. (2003) Supply Chain Collaboration: The Key Value Creation. Work Study, 52, 76-83. http://dx.doi.org/10.1108/00438020310462872
[35] Hira, A. (2009) The Political Economy of the Global Pharma-ceutical Industry: Why the Poor Lack Access to Medicine and What Might Be Done about It. International Journal of Development Issues, 8, 84-101. http://dx.doi.org/10.1108/14468950910997666
[36] Conle, M. and Taube, M. (2010) Regional Specialization in China’s Biopharmaceutical Industry. Chinese Management Studies, 4, 339-359. http://dx.doi.org/10.1108/17506141011094136
[37] Lau, K.H. and Zhang, J. (2006) Drivers and Obstacles of Out-sourcing Practices in China. International Journal of Physical Distribution and Logistics Management, 36, 776-792. http://dx.doi.org/10.1108/09600030610714599
[38] Gr??ler, A., Laugen, B.T., Arkader, R. and Fleury, A. (2013) Differences in Outsourcing Strategies between Firms in Emerging and Developed Markets. International Journal of Operation and Production Management, 33, 296-321. http://dx.doi.org/10.1108/01443571311300791
[39] Elango, B. (2008) Using Outsourcing for Strategic Competitiveness in Small and Medium-sized Firms. Competitiveness Review: An International Business Journal, 18, 322-332. http://dx.doi.org/10.1108/10595420810920806
[40] Rapp, A. (2009) Outsourcing the Sales Process: Hiring a Merce-nary Sales Force. Industrial Marketing Management, 38, 411-418. http://dx.doi.org/10.1016/j.indmarman.2009.03.006
[41] Whitworth, M. (2005) Outsourced Security—The Benefits and Risks. Network Security, 2005, 16-19. http://dx.doi.org/10.1016/S1353-4858(05)70292-0
[42] Yin, R.K. (2012) Applications of Case Study Research. 3rd Edition, SAGA Publication, Inc.
[43] Yin, R.K. (2014) Case Study Research: Design and Methods. 5th Edition, SAGA Publications, Inc.
[44] Herriott, R.E. and Firestone, W.A. (1983) Multisite Qualitative Research: Optimizing Description and Generalizability. Education Researcher, 12, 14-19.
[45] Chung, H.F.L., Yang, Z. and Huang, P. (2015) How Does Organizational Learning Matter in Strategic Business Performance? The Contingency Role of Guangxi Networking. Journal of Business Research, 68, 1216-1224. http://dx.doi.org/10.1016/j.jbusres.2014.11.016

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.